Table 4 Treatment choice - univariate analysis
From: Management of osteoporosis and associated quality of life in post menopausal women
BP Weekly N = 462 | BP Monthly N = 388 | Strontium Ranelate N = 182 | SERM N = 115 | p | Total N = 1180 | ||
|---|---|---|---|---|---|---|---|
Physician speciality | Rheumatologists | 122 (26.4%) | 086 (22.2%) | 053 (29.1%) | 022 (19.1%) | ≤ 0.001 | 283 (24.7%) |
Gynaecologists | 044 (09.5%) | 038 (09.8%) | 047 (25.8%) | 036 (31.3%) | 165 (14.4%) | ||
GPs | 296 (64.1%) | 264 (68.0%) | 082 (45.1%) | 057 (49.6%) | 699 (60.9%) | ||
Age | Mean ± SD | 67.3 ± 9.2 | 66.9 ± 8.1 | 65.3 ± 9.3 | 60.00 ± 6.0 | ≤ 0.001 | 66.1 ± 8.9 |
Missing data | 1 | 0 | 1 | 0 | 2 | ||
Time since menopause (years) | Mean ± SD | 17.3 ± 9.6 | 17.2 ± 9.0 | 15.7 ± 9.8 | 10.2 ± 6.3 | ≤ 0.001 | 16.3 ± 9.4 |
Missing data | 5 | 3 | 1 | 3 | 12 | ||
Type of osteoporosis diagnosis | Low BMD + osteoporotic fracture | 097 (21.0%) | 060 (15.5%) | 031 (17.0%) | 008 (07.0%) | ≤ 0.001 | 196 (17.1%) |
Low BMD without osteoporotic fracture | 271 (58.7%) | 259 (66.8%) | 106 (58.2%) | 097 (84.4%) | 733 (63.9%) | ||
Osteoporotic fracture without low BMD | 094 (20.4%) | 069 (17.8%) | 045 (24.7%) | 010 (08.7%) | 218 (19.0%) | ||
BMD | N (%) | 391 (84.8%) | 331 (86.0%) | 159 (87.9%) | 108 (93.9%) | 0.057 | 989 (86.6%) |
Missing data | 1 | 3 | 1 | 0 | 5 | ||
Mean Hip T-score | Mean ± SD | -2.24 ± 1.12 | -2.34 ± 0.79 | -2.33 ± 1.01 | -1.81 ± 1.40 | 0.004 | -2.24 ± 1.05 |
Missing data | 1 | 1 | 1 | 0 | 3 | ||
T-Score by class | Normal BMD (Tscore>-1) | 1 (0.3%) | 0 (0.0%) | 1 (0.7%) | 000 (00.0%) | 0.074 | 002 (00.2%) |
Osteopenia (-2.5 < Tscore <-1) | 30 (8.7%) | 16 (05.5%) | 7 (5.0%) | 012 (13.0%) | 065 (07.5%) | ||
Osteoporosis (Tscore≤-2.5) | 313 (91.0%) | 275 (94.5%) | 131 (94.2%) | 080 (87.0%) | 799 (92.3%) | ||
Missing data | 47 | 40 | 20 | 16 | 127 | ||
Osteoporotic fractures | 230 (51.6%) | 169 (46.3%) | 95 (54.0%) | 27 (25.0%) | ≤ 0.001 | 521 (47.6%) | |
Missing data | 16 | 23 | 6 | 7 | 52 | ||
Fractures in the previous 6 months | 205 (44.7%) | 151 (39.3%) | 89 (49.2%) | 023 (20.0%) | ≤ 0.001 | 468 (41.1%) | |
Missing data | 3 | 4 | 1 | 0 | 8 | ||
Number of fractures in the previous 6 months | 1.28 ± 0.62 | 1.47 ± 0.88 | 1.40 ± 0.73 | 1.33 ± 0.58 | 0.195 | 1.37 ± 0.74 | |
Missing data | 24 | 17 | 6 | 2 | 49 | ||
Long-term corticosteroid treatment (> 3 months) | 47 (10.2%) | 36 (9.3%) | 11 (6.0%) | 5 (4.4%) | 0.122 | 99 (8.6%) | |
Ongoing treatment at the time of consultation | 301 (65.2%) | 216 (55.7%) | 114 (62.6%) | 066 (57.4%) | 0.032 | 697 (60.8%) | |
Paraclinical investigations | 433 (93.7%) | 374 (96.6%) | 175 (96.2%) | 105 (91.3%) | 0.057 | 1087 (94.9% | |